EUVIMEDEUVIMED entdecken
Studienprotokoll

Novel Protocol of Opium Tincture Oral Usage in Two Cases with Chronic Myeloid Leukemia and Hodgkin Lymphoma

Hossein Dezhakam, Amin Dezhakam, Ani Dezhakam, Shani Dezhakam, Arvin Haghighatfard

Mathews Journal of Gastroenterology and Hepatology · 2023

DOI: 10.30654/mjgh.10021 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Mathews Journal of Gastroenterology and Hepatology, 2023. Verfasst von Hossein Dezhakam und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We report two cases of chronic myeloid leukemia (CML).The first patient was a 40-year-old man who presented with a prolonged history of upper abdominal discomfort, anorexia, and with fever.Examination revealed moderate hepatosplenomegaly.Examinations showed that he was found to have leucocytosis with moderate anemia.Given the leucocytosis, he was investigated for CML and found to be positive for BCR-ABL by Realtime PCR.He received imatinib 400 mg/day and achieved a complete hematological response at the end of 3 months.The second patient was a 40-year-old male diagnosed with Hodgkin lymphoma based on a Lymph node biopsy.He completed five cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) chemotherapy.Both patients were previously addicted to opium and before the cancer diagnosis, these patients were successfully treated for their addiction with a new method of using opium tincture called Dezhakam step time (DST).After the diagnosis of cancer, both patients were treated with opium tincture using a new protocol of taper up-off that took about 11 months.Both patients showed significant clinical improvement along with a dramatic reduction of pain and no craving or dependence symptoms during and after the treatment.

Zitieren

APA

Dezhakam, H., Dezhakam, A., Dezhakam, A., Dezhakam, S., & Haghighatfard, A. (2023). Novel Protocol of Opium Tincture Oral Usage in Two Cases with Chronic Myeloid Leukemia and Hodgkin Lymphoma. Mathews Journal of Gastroenterology and Hepatology. https://doi.org/10.30654/mjgh.10021

Vancouver

Dezhakam H, Dezhakam A, Dezhakam A, Dezhakam S, Haghighatfard A. Novel Protocol of Opium Tincture Oral Usage in Two Cases with Chronic Myeloid Leukemia and Hodgkin Lymphoma. Mathews Journal of Gastroenterology and Hepatology. 2023. doi:10.30654/mjgh.10021

BibTeX
@article{Dezhakam2023,
  author = {Dezhakam, Hossein and Dezhakam, Amin and Dezhakam, Ani and Dezhakam, Shani and Haghighatfard, Arvin},
  title = {Novel Protocol of Opium Tincture Oral Usage in Two Cases with Chronic Myeloid Leukemia and Hodgkin Lymphoma},
  journal = {Mathews Journal of Gastroenterology and Hepatology},
  year = {2023},
  doi = {10.30654/mjgh.10021}
}
Kostenlos starten →